author_facet Cartei, G.
Zustovich, F.
Murrone, A.
Zovato, S.
Binato, S.
Mattiazzi, M.
Farinati, F.
Zanus, G.
Cillo, U.
Pastorelli, D.
Cartei, G.
Zustovich, F.
Murrone, A.
Zovato, S.
Binato, S.
Mattiazzi, M.
Farinati, F.
Zanus, G.
Cillo, U.
Pastorelli, D.
author Cartei, G.
Zustovich, F.
Murrone, A.
Zovato, S.
Binato, S.
Mattiazzi, M.
Farinati, F.
Zanus, G.
Cillo, U.
Pastorelli, D.
spellingShingle Cartei, G.
Zustovich, F.
Murrone, A.
Zovato, S.
Binato, S.
Mattiazzi, M.
Farinati, F.
Zanus, G.
Cillo, U.
Pastorelli, D.
Journal of Clinical Oncology
A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
Cancer Research
Oncology
author_sort cartei, g.
spelling Cartei, G. Zustovich, F. Murrone, A. Zovato, S. Binato, S. Mattiazzi, M. Farinati, F. Zanus, G. Cillo, U. Pastorelli, D. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2005.23.16_suppl.4227 A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy Journal of Clinical Oncology
doi_str_mv 10.1200/jco.2005.23.16_suppl.4227
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAwNS4yMy4xNl9zdXBwbC40MjI3
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAwNS4yMy4xNl9zdXBwbC40MjI3
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Zwi2
imprint American Society of Clinical Oncology (ASCO), 2005
imprint_str_mv American Society of Clinical Oncology (ASCO), 2005
issn 0732-183X
1527-7755
issn_str_mv 0732-183X
1527-7755
language English
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
match_str cartei2005aphaseiiistudyofliposomaldoxorubicinldinthetreatmentofhepatocellularcarcinomahccnotsuitableforlocoregionaltherapy
publishDateSort 2005
publisher American Society of Clinical Oncology (ASCO)
recordtype ai
record_format ai
series Journal of Clinical Oncology
source_id 49
title A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
title_unstemmed A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
title_full A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
title_fullStr A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
title_full_unstemmed A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
title_short A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
title_sort a phase i-ii study of liposomal doxorubicin (ld) in the treatment of hepatocellular carcinoma (hcc) not suitable for loco-regional therapy
topic Cancer Research
Oncology
url http://dx.doi.org/10.1200/jco.2005.23.16_suppl.4227
publishDate 2005
physical 4227-4227
description
container_issue 16_suppl
container_start_page 4227
container_title Journal of Clinical Oncology
container_volume 23
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792327788304269313
geogr_code not assigned
last_indexed 2024-03-01T12:42:57.914Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+phase+I-II+study+of+liposomal+doxorubicin+%28LD%29+in+the+treatment+of+hepatocellular+carcinoma+%28HCC%29+not+suitable+for+loco-regional+therapy&rft.date=2005-06-01&genre=article&issn=1527-7755&volume=23&issue=16_suppl&spage=4227&epage=4227&pages=4227-4227&jtitle=Journal+of+Clinical+Oncology&atitle=A+phase+I-II+study+of+liposomal+doxorubicin+%28LD%29+in+the+treatment+of+hepatocellular+carcinoma+%28HCC%29+not+suitable+for+loco-regional+therapy&aulast=Pastorelli&aufirst=D.&rft_id=info%3Adoi%2F10.1200%2Fjco.2005.23.16_suppl.4227&rft.language%5B0%5D=eng
SOLR
_version_ 1792327788304269313
author Cartei, G., Zustovich, F., Murrone, A., Zovato, S., Binato, S., Mattiazzi, M., Farinati, F., Zanus, G., Cillo, U., Pastorelli, D.
author_facet Cartei, G., Zustovich, F., Murrone, A., Zovato, S., Binato, S., Mattiazzi, M., Farinati, F., Zanus, G., Cillo, U., Pastorelli, D., Cartei, G., Zustovich, F., Murrone, A., Zovato, S., Binato, S., Mattiazzi, M., Farinati, F., Zanus, G., Cillo, U., Pastorelli, D.
author_sort cartei, g.
container_issue 16_suppl
container_start_page 4227
container_title Journal of Clinical Oncology
container_volume 23
description
doi_str_mv 10.1200/jco.2005.23.16_suppl.4227
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAwNS4yMy4xNl9zdXBwbC40MjI3
imprint American Society of Clinical Oncology (ASCO), 2005
imprint_str_mv American Society of Clinical Oncology (ASCO), 2005
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2
issn 0732-183X, 1527-7755
issn_str_mv 0732-183X, 1527-7755
language English
last_indexed 2024-03-01T12:42:57.914Z
match_str cartei2005aphaseiiistudyofliposomaldoxorubicinldinthetreatmentofhepatocellularcarcinomahccnotsuitableforlocoregionaltherapy
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
physical 4227-4227
publishDate 2005
publishDateSort 2005
publisher American Society of Clinical Oncology (ASCO)
record_format ai
recordtype ai
series Journal of Clinical Oncology
source_id 49
spelling Cartei, G. Zustovich, F. Murrone, A. Zovato, S. Binato, S. Mattiazzi, M. Farinati, F. Zanus, G. Cillo, U. Pastorelli, D. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2005.23.16_suppl.4227 A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy Journal of Clinical Oncology
spellingShingle Cartei, G., Zustovich, F., Murrone, A., Zovato, S., Binato, S., Mattiazzi, M., Farinati, F., Zanus, G., Cillo, U., Pastorelli, D., Journal of Clinical Oncology, A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy, Cancer Research, Oncology
title A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
title_full A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
title_fullStr A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
title_full_unstemmed A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
title_short A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
title_sort a phase i-ii study of liposomal doxorubicin (ld) in the treatment of hepatocellular carcinoma (hcc) not suitable for loco-regional therapy
title_unstemmed A phase I-II study of liposomal doxorubicin (LD) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
topic Cancer Research, Oncology
url http://dx.doi.org/10.1200/jco.2005.23.16_suppl.4227